The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP
Siyuan Sun(Second Affiliated Hospital of Zhejiang University), Huidi Jiang(Zhejiang Pharmaceutical College), Hao Pan(Chinese Academy of Sciences), Su Zeng(Shanghai University of Traditional Chinese Medicine), Zhongjian Chen(Zhejiang University), Min Huang(Chinese Academy of Sciences), Dongli Sun(Zhejiang University), Liping Li(Zhejiang University), Ye Tian(Second Military Medical University), Huichang Bi(Southern Medical University)
Cited by 27
Related Papers
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
|Cell|2018|271
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death
|Journal of Pharmacology and Experimental Therapeutics|2008|248
Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury
|The FASEB Journal|2007|240
Identification of seven serum microRNAs from a genome‐wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas
|International Journal of Cancer|2012|193